However, T cells eventually fail to eradicate the tumor in all cancer patients, and cytotoxic CD8+ T cells present in the tumor microenvironment of lung cancer patients were actually observed to be hyporesponsive to activation via the T cell receptor (TCR) and less effective compared to those exposed to a non-tumor environment [29]. Here, CD8A is linked to lung cancer.